NTN BUZZTIME INC (74)

Browse by Contract Category

Contracts

Angel Offer Letter, dated December 30, 2022, by and among Eterna Therapeutics Inc. and Dr. Matthew Angel (Filed With SEC on January 4, 2023)
Registration Rights Agreement, dated as of December 2, 2022, by and among Eterna Therapeutics Inc. and the purchasers party thereto (Filed With SEC on December 5, 2022)
First Amendment to Exclusive License Agreement, dated November 22, 2022, by and among Eterna Therapeutics Inc., Brooklyn Immunotherapeutics LLC, Novellus Therapeutics Limited and... (Filed With SEC on November 22, 2022)
Master Services Agreement, dated September 9, 2022, by and between Factor Bioscience Inc. and Brooklyn ImmunoTherapeutics, Inc (Filed With SEC on September 15, 2022)
Separation Agreement and General Release, dated August 24, 2022, by and between Brooklyn ImmunoTherapeutics, Inc. and Kevin DAmour (Filed With SEC on September 1, 2022)
Torrey Pines Science Center Lease, dated March 31, 2022, between Brooklyn ImmunoTherapeutics, Inc. and Torrey Pines Science Center Limited Partnership (Filed With SEC on August 11, 2022)
Agreement and Plan of Merger and Reorganization, dated August 12, 2020, among NTN Buzztime, Inc., BIT Merger Sub, Inc. and Brooklyn Immunotherapeutics LLC (Filed With SEC on August 14, 2020)
Form of Warrant (Filed With SEC on December 5, 2022)
Third Amended and Restated Exclusive License Agreement, dated November 1, 2020, by and between Factor Bioscience Limited and Novellus Therapeutics Limited (Filed With SEC on November 14, 2022)
Option Agreement, dated October 8, 2022, by and between Exacis Biotherapeutics, Inc. and Brooklyn ImmunoTherapeutics, Inc (Filed With SEC on October 14, 2022)
Assignment and Assumption of Lease dated March 25, 2022 between Brooklyn ImmunoTherapeutics, LLC and Regen Lab USA LLC (Filed With SEC on July 1, 2022)
Agreement to Assign Space Lease dated March 5, 2022 between Brooklyn ImmunoTherapeutics, LLC and Regen Lab USA LLC (Filed With SEC on July 1, 2022)
Separation Agreement and General Release, dated May 25, 2022, by and between Brooklyn ImmunoTherapeutics, Inc. and Howard J. Federoff (Filed With SEC on May 31, 2022)
Amended and Restated Executive Employment Agreement, dated as of May 10, 2022, by and between Brooklyn ImmunoTherapeutics, Inc. and Andrew Jackson (Filed With SEC on May 31, 2022)
Lease Agreement dated June 15, 2021 between Brooklyn ImmunoTherapeutics, Inc. and Fairlane Columbia, LLC (Filed With SEC on April 15, 2022)
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 15, 2022)
Securities Purchase Agreement, dated as of March 6, 2022, between Brooklyn ImmunoTherapeutics, Inc. and the purchaser party thereto (Filed With SEC on March 9, 2022)
Form of Pre-Funded Warrant (Filed With SEC on March 9, 2022)
Form of Common Stock Warrant (Filed With SEC on March 9, 2022)
Registration Rights Agreement, dated as of March 6, 2022, between Brooklyn ImmunoTherapeutics, Inc. and the purchaser party thereto (Filed With SEC on March 9, 2022)
Schedule identifying agreements substantially identical to the form of indemnification agreement filed as Exhibit 10.4(a) (Filed With SEC on November 12, 2021)
Executive Employment Agreement effective as of September 20, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Roger Sidhu (Filed With SEC on September 23, 2021)
Agreement and Plan of Acquisition, dated as of July 16, 2021, by and among Brooklyn ImmunoTherapeutics, Inc., Brooklyn Acquisition Sub, Inc., Novellus LLC, Novellus, Inc., and the... (Filed With SEC on July 19, 2021)
Executive Employment Agreement, dated as of July 6, 2021 and effective as of July 15, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Jay Sial (Filed With SEC on July 19, 2021)
Registration Rights Agreement, dated as of July 16, 2021, by and among Brooklyn ImmunoTherapeutics, Inc. and the individuals and entities named therein (Filed With SEC on July 19, 2021)
Executive Employment Agreement, dated as of June 16, 2021 and effective as of June 21, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Sandra Gurrola (Filed With SEC on June 21, 2021)
Schedule identifying agreements substantially identical to the form of Indemnification Agreement filed as Exhibit 10.2 (Filed With SEC on June 21, 2021)
Executive Employment Agreement, dated as of June 5, 2021 and effective as of June 28, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Kevin A. DAmour (Filed With SEC on June 10, 2021)
Brooklyn ImmunoTherapeutics, Inc. 2021 Inducement Stock Incentive Plan (Filed With SEC on May 26, 2021)
Registration Rights Agreement, dated as of May 26, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 26, 2021)
Purchase Agreement, dated as of May 26, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 26, 2021)
Schedule identifying agreements substantially identical to the form of Indemnification Agreement filed as Exhibit 10.1 (Filed With SEC on May 11, 2021)
Registration Rights Agreement, dated as of April 26, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2021)
Schedule identifying agreements substantially identical to the form of Indemnification Agreement filed as Exhibit 10.9 (Filed With SEC on April 30, 2021)
Description of registrants securities (Filed With SEC on April 30, 2021)
Specimen stock certificate evidencing shares of common stock of Brooklyn ImmunoTherapeutics, Inc (Filed With SEC on April 30, 2021)
Exclusive License Agreement, dated as of April 26, 2021, between Factor Bioscience Limited, Novellus Therapeutics Limited and Brooklyn ImmunoTherapeutics LLC (Filed With SEC on April 30, 2021)
Purchase Agreement, dated as of April 26, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2021)
Schedule identifying agreements substantially identical to the form of indemnification agreement filed as Exhibit 10.1 (Filed With SEC on April 16, 2021)
Form of Indemnification Agreement (Filed With SEC on April 16, 2021)
Executive Employment Agreement, dated as of April 1, 2021 and effective as of April 16, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Howard J. Federoff (Filed With SEC on April 7, 2021)
Assignment and Assumption of Employment Agreement dated March 30, 2021 among Brooklyn ImmunoTherapeutics LLC, Brooklyn ImmunoTherapeutics, Inc. and Lynn Sadowski Mason (Filed With SEC on March 31, 2021)
Assignment and Assumption of Employment Agreement dated March 30, 2021 among Brooklyn ImmunoTherapeutics LLC, Brooklyn ImmunoTherapeutics, Inc. and Ronald Guido (Filed With SEC on March 31, 2021)
Brooklyn ImmunoTherapeutics, Inc. 2020 Stock Incentive Plan (Filed With SEC on March 31, 2021)
Amended and Restated Royalty Agreement and Distribution Agreement, dated as of March 22, 2021 (Filed With SEC on March 31, 2021)
10% Promissory Note issued by NTN Buzztime, Inc. on January 12, 2021 (Filed With SEC on January 15, 2021)
Second Omnibus Amendment and Agreement dated January 12, 2021 by and between NTN Buzztime, Inc., eGames.com Holdings LLC and Fertilemind Management, LLC (Filed With SEC on January 15, 2021)
10% Promissory Note to be issued by NTN Buzztime, Inc. on December 1, 2020 (Filed With SEC on November 23, 2020)
Omnibus Amendment and Agreement dated November 19, 2020 by and between NTN Buzztime, Inc., eGames.com Holdings LLC and Fertilemind Management, LLC (Filed With SEC on November 23, 2020)
Guaranty by Aram Fuchs in favor of NTN Buzztime, Inc (Filed With SEC on September 18, 2020)
Amendment #4 to Employment Agreement made and entered into as of September 18, 2020 between NTN Buzztime, Inc. and Allen Wolff (Filed With SEC on September 18, 2020)
8% Promissory Note issued by NTN Buzztime, Inc. on September 18, 2020 (Filed With SEC on September 18, 2020)
Asset Purchase Agreement dated September 18, 2020 by and between NTN Buzztime, Inc. and eGames.com Holdings LLC (Filed With SEC on September 18, 2020)
Form of Support Agreement among NTN Buzztime, Inc., Brooklyn Immunotherapeutics LLC and the officers and directors of NTN Buzztime, Inc. (solely in their capacity as actual or... (Filed With SEC on August 14, 2020)
Form of Support Agreement among NTN Buzztime, Inc., Brooklyn Immunotherapeutics LLC and certain beneficial holders of Class A membership interests of Brooklyn Immunotherapeutics... (Filed With SEC on August 14, 2020)
Second Amendment to Loan and Security Agreement dated June 1, 2020 between NTN Buzztime, Inc. and Avidbank (Filed With SEC on August 10, 2020)
Lease Termination, Surrender and Buy-Out Agreement dated June 25, 2020 between NTN Buzztime, Inc. and Burke Aston Partners, LLC (Filed With SEC on July 1, 2020)
NTN Buzztime, Inc. Executive Incentive Plan for Eligible Employees of NTN Buzztime, Inc. Fiscal Year 2020 (Filed With SEC on June 2, 2020)
Retention Bonus and General Release of All Claims Agreement dated May 27, 2020 by and between NTN Buzztime, Inc. and Sandra Gurrola (Filed With SEC on June 2, 2020)
Second Amendment to Employment Agreement dated May 27, 2020 by and between NTN Buzztime, Inc. and Sandra Gurrola (Filed With SEC on June 2, 2020)
Acknowledgment and Agreement Regarding Loan Forgiveness dated April 18, 2020 (Filed With SEC on April 21, 2020)
Paycheck Protection Program Note dated April 18, 2020 issued by NTN Buzztime, Inc. in favor of Level One Bank (Filed With SEC on April 21, 2020)
Third Amendment to Employment Agreement dated March 27, 2020 by and between NTN Buzztime, Inc. and Allen Wolff (Filed With SEC on March 30, 2020)
Description of securities of the registrant (Filed With SEC on March 19, 2020)
First Amendment to Loan and Security Agreement dated as of March 12, 2020, between NTN Buzztime, Inc. and Avidbank (Filed With SEC on March 17, 2020)
First Amendment to Employment Agreement dated January 14, 2020 by and between NTN Buzztime, Inc. and Sandra Gurrola (Filed With SEC on January 15, 2020)
Second Amendment to Employment Agreement dated January 14, 2020 by and between NTN Buzztime, Inc. and Allen Wolff (Filed With SEC on January 15, 2020)
Asset purchase agreement dated January 13, 2020 between NTN Buzztime, Inc. and Sporcle, Inc (Filed With SEC on January 15, 2020)
Employment Agreement dated September 17, 2019 by and between NTN Buzztime, Inc. and Sandra Gurrola (Filed With SEC on September 17, 2019)
First Amendment to Employment Agreement dated September 17, 2019 by and between NTN Buzztime, Inc. and Allen Wolff (Filed With SEC on September 17, 2019)
Limited Term Employment and Separation Agreement and General Release of All Claims dated Separation 17, 2019 by and between NTN Buzztime, Inc. and Ram Krishnan (Filed With SEC on September 17, 2019)
2019 Interim CEO Performance Incentive Plan (Filed With SEC on September 17, 2019)
Form of Director and Officer Indemnification Agreement (Filed With SEC on March 22, 2019)
The NTN Buzztime, Inc. Executive Incentive Plan for Eligible Employees of NTN Buzztime, Inc. Fiscal Year 2019 dated March 19, 2019 (Filed With SEC on March 20, 2019)